The Valley Desk

ArticleIntestinal researchPublished

Guselkumab efficacy and safety in East Asian participants with moderately to severely active Crohn's disease: subgroup analysis of the phase 3 GALAXI 2 and GALAXI 3 trials

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
Intestinal research
Published
Subject terms
Asia; Clinical Trial; Crohn Disease; Guselkumab
PubMed ID
42415265
Added to directory
Source checked

Report a correction or request removal